Shrydus Industries Ltd
Incorporation in 1983, Shrydus Industries Ltd is in the business of healthcare, pharma, real estate and green energy[1]
- Market Cap ₹ 16.5 Cr.
- Current Price ₹ 5.14
- High / Low ₹ 29.0 / 3.78
- Stock P/E 22.6
- Book Value ₹ 13.3
- Dividend Yield 0.00 %
- ROCE 2.48 %
- ROE 3.00 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.38 times its book value
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -2.81% over past five years.
- Promoter holding is low: 25.9%
- Company has a low return on equity of 5.24% over last 3 years.
- Company has high debtors of 308 days.
- Promoter holding has decreased over last 3 years: -14.0%
- Working capital days have increased from 391 days to 929 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.02 | 0.01 | 0.44 | 0.27 | 0.23 | 0.00 | 5.20 | 2.48 | 9.00 | 9.29 | 9.45 | 4.51 | |
0.17 | 1.34 | 0.59 | 0.38 | 0.24 | 2.45 | 5.25 | 2.75 | 8.94 | 9.02 | 8.93 | 3.77 | |
Operating Profit | -0.15 | -1.33 | -0.15 | -0.11 | -0.01 | -2.45 | -0.05 | -0.27 | 0.06 | 0.27 | 0.52 | 0.74 |
OPM % | -750.00% | -13,300.00% | -34.09% | -40.74% | -4.35% | -0.96% | -10.89% | 0.67% | 2.91% | 5.50% | 16.41% | |
0.01 | 1.35 | -0.01 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax | -0.15 | 0.02 | -0.16 | -0.11 | -0.01 | -2.38 | -0.05 | -0.27 | 0.06 | 0.29 | 0.52 | 0.74 |
Tax % | 0.00% | -450.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 16.67% | -3.45% | 0.00% | 0.00% |
-0.15 | 0.11 | -0.16 | -0.11 | -0.01 | -2.38 | -0.05 | -0.27 | 0.04 | 0.30 | 0.52 | 0.73 | |
EPS in Rs | -0.06 | 0.05 | -0.07 | -0.05 | -0.00 | -0.99 | -0.02 | -0.11 | 0.02 | 0.12 | 0.16 | 0.23 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 84% |
5 Years: | -3% |
3 Years: | -21% |
TTM: | -52% |
Compounded Profit Growth | |
---|---|
10 Years: | 10% |
5 Years: | 75% |
3 Years: | 163% |
TTM: | 40% |
Stock Price CAGR | |
---|---|
10 Years: | 17% |
5 Years: | 28% |
3 Years: | 31% |
1 Year: | -68% |
Return on Equity | |
---|---|
10 Years: | -3% |
5 Years: | 4% |
3 Years: | 5% |
Last Year: | 3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.06 | 9.66 | 12.01 | 32.02 |
Reserves | -5.52 | -5.41 | -5.58 | -5.68 | -5.69 | -8.08 | -8.12 | -8.39 | -8.35 | -7.75 | -6.05 | 10.70 |
0.33 | 0.01 | 0.35 | 0.01 | 0.06 | 0.00 | 0.02 | 0.24 | 1.72 | 1.86 | 10.91 | 0.02 | |
0.62 | 0.51 | 0.55 | 0.52 | 0.53 | 0.02 | 5.15 | 2.57 | 2.27 | 3.14 | 0.02 | 0.02 | |
Total Liabilities | 4.49 | 4.17 | 4.38 | 3.91 | 3.96 | 1.00 | 6.11 | 3.48 | 4.70 | 6.91 | 16.89 | 42.76 |
0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 1.84 | 0.09 | 0.08 | 0.08 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
2.57 | 4.08 | 4.30 | 3.83 | 3.88 | 1.00 | 6.11 | 3.48 | 4.70 | 6.91 | 16.89 | 42.74 | |
Total Assets | 4.49 | 4.17 | 4.38 | 3.91 | 3.96 | 1.00 | 6.11 | 3.48 | 4.70 | 6.91 | 16.89 | 42.76 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.12 | -3.49 | 0.25 | 0.07 | 0.04 | -0.40 | 0.13 | -0.31 | -1.51 | -0.15 | -13.46 | -25.14 | |
-0.01 | 4.17 | -0.40 | -0.29 | -0.09 | 0.93 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | |
0.13 | -0.32 | 0.35 | -0.34 | 0.05 | -0.55 | 0.02 | 0.22 | 1.48 | 1.04 | 12.58 | 25.13 | |
Net Cash Flow | 0.00 | 0.35 | 0.20 | -0.56 | 0.00 | -0.03 | 0.15 | -0.09 | -0.03 | 0.88 | -0.88 | -0.03 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0.00 | 0.00 | 16.59 | 27.04 | 0.00 | 365.00 | 390.02 | 158.57 | 200.77 | 132.87 | 308.35 | |
Inventory Days | 861.89 | 2,199.12 | 4,051.50 | 13.52 | 28.19 | 8.01 | 7.85 | 16.95 | 1,613.47 | |||
Days Payable | 0.00 | 0.00 | 0.00 | 365.00 | 378.35 | 94.41 | 128.97 | 0.00 | 0.00 | |||
Cash Conversion Cycle | 0.00 | 861.89 | 2,215.72 | 4,078.54 | 0.00 | 13.52 | 39.86 | 72.17 | 79.65 | 149.81 | 1,921.81 | |
Working Capital Days | -730.00 | 101,835.00 | 1,982.61 | 2,987.59 | 3,427.83 | 18.25 | 44.15 | 75.43 | 90.76 | 152.57 | 929.09 | |
ROCE % | -3.87% | -34.79% | -4.01% | -3.05% | -0.29% | -110.66% | -5.15% | -28.88% | 3.59% | 9.35% | 5.04% | 2.48% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2 Jun - Newspaper Publication for Audited Standalone and consolidated financial result for the year ended 2025
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Secretarial Compliance Report for FY ended 31 Mar 2025 filed by Shrydus Industries Limited.
-
Audited Standalone And Consolidated Financial Result For The Year Ended March 2025
30 May - Audited Q4 and FY25 financial results approved; secretarial auditor appointed for 5 years.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th May, 2025 For Approve The Audited Standalone And Consolidated Financial Result For Year Ended March 2025
30 May - Shrydus Industries approved audited FY25 standalone and consolidated results; appointed secretarial auditor for 5 years.
-
Board Meeting Intimation for Board Meeting Is Schedule On 30Th May, 2025 For Approve The Audited Standalone And Consolidated Finacial Result For The Financial Year March 31, 2025
23 May - Board meeting on 30 May 2025 to approve audited financial results for FY 2025.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
SIL (formerly VCK Capital Market Services Ltd) is an integrated and diversified corporate group which has ventured into multiple businesses. It was into Agricultural Commodities and Healthcare products business and is now diversifying in Pharmaceutical Formulation Plant, Astra Lifecare Pvt. Ltd., and Green Energy sector